Login / Signup

Assessment of the soluble proteins HMGB1, CD40L and CD62P during various platelet preparation processes and the storage of platelet concentrates: The BEST collaborative study.

Fabrice CognasseHind Hamzeh-CognasseMarie Ange EyraudAmélie PrierCharles Antoine ArthaudPierre TiberghienStephane BegueDirk de KorteEric GouwerokAndreas GreinacherKonstanze AurichFemke NoormanLarry J DumontKathleen K KellyMarc CloutierRenée BazinRebecca CardiganSian HuishPeter A SmethurstDana V DevinePeter SchubertLacey JohnsonDenese C Marksnull null
Published in: Transfusion (2022)
The HMGB1 release mechanism/intracellular pathways appear to differ from sCD62P and sCD40L. The extent to which these differences affect patient outcomes, particularly post-transfusion platelet increment and adverse events, warrants further investigation in clinical trials with various therapeutic indications.
Keyphrases
  • clinical trial
  • cardiac surgery
  • nk cells
  • randomized controlled trial
  • molecularly imprinted
  • mass spectrometry
  • acute kidney injury